• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒对细胞信号的失调调控。

Dysregulation of Cell Signaling by SARS-CoV-2.

机构信息

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA.

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.

出版信息

Trends Microbiol. 2021 Mar;29(3):224-237. doi: 10.1016/j.tim.2020.12.007. Epub 2020 Dec 19.

DOI:10.1016/j.tim.2020.12.007
PMID:33451855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836829/
Abstract

Pathogens usurp host pathways to generate a permissive environment for their propagation. The current spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection presents the urgent need to understand the complex pathogen-host interplay for effective control of the virus. SARS-CoV-2 reorganizes the host cytoskeleton for efficient cell entry and controls host transcriptional processes to support viral protein translation. The virus also dysregulates innate cellular defenses using various structural and nonstructural proteins. This results in substantial but delayed hyperinflammation alongside a weakened interferon (IFN) response. We provide an overview of SARS-CoV-2 and its uniquely aggressive life cycle and discuss the interactions of various viral proteins with host signaling pathways. We also address the functional changes in SARS-CoV-2 proteins, relative to SARS-CoV. Our comprehensive assessment of host signaling in SARS-CoV-2 pathogenesis provides some complex yet important strategic clues for the development of novel therapeutics against this rapidly emerging worldwide crisis.

摘要

病原体篡夺宿主途径,为其繁殖生成一个许可的环境。目前严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的广泛传播迫切需要了解复杂的病原体-宿主相互作用,以有效控制病毒。SARS-CoV-2 重组宿主细胞骨架以实现有效的细胞进入,并控制宿主转录过程以支持病毒蛋白翻译。该病毒还利用各种结构和非结构蛋白来失调先天细胞防御。这导致大量但延迟的过度炎症以及干扰素(IFN)反应减弱。我们提供了 SARS-CoV-2 的概述及其独特的侵袭性生命周期,并讨论了各种病毒蛋白与宿主信号通路的相互作用。我们还讨论了 SARS-CoV-2 蛋白相对于 SARS-CoV 的功能变化。我们对 SARS-CoV-2 发病机制中宿主信号的全面评估为针对这一迅速出现的全球危机开发新型治疗方法提供了一些复杂但重要的战略线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2845/7836829/ec01c282fcd4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2845/7836829/ec01c282fcd4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2845/7836829/ec01c282fcd4/gr1_lrg.jpg

相似文献

1
Dysregulation of Cell Signaling by SARS-CoV-2.新冠病毒对细胞信号的失调调控。
Trends Microbiol. 2021 Mar;29(3):224-237. doi: 10.1016/j.tim.2020.12.007. Epub 2020 Dec 19.
2
SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.SARS-CoV-2 非结构蛋白 1 通过导致关键宿主信号因子耗竭来抑制干扰素反应。
J Virol. 2021 Jun 10;95(13):e0026621. doi: 10.1128/JVI.00266-21.
3
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.SARS-CoV-2 与同源冠状病毒非结构蛋白的比较多重相互作用组学鉴定了独特和共享的宿主细胞依赖性。
ACS Infect Dis. 2020 Dec 11;6(12):3174-3189. doi: 10.1021/acsinfecdis.0c00500. Epub 2020 Dec 2.
4
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.定义 SARS-CoV-2-人巨噬细胞相互作用的固有免疫反应。
Front Immunol. 2021 Oct 4;12:741502. doi: 10.3389/fimmu.2021.741502. eCollection 2021.
5
Host proviral and antiviral factors for SARS-CoV-2.宿主内有利于 SARS-CoV-2 的病毒前体和抗病毒因子。
Virus Genes. 2021 Dec;57(6):475-488. doi: 10.1007/s11262-021-01869-2. Epub 2021 Sep 11.
6
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.SARS-CoV 感染周期:病毒膜蛋白、功能相互作用及其发病机制概述。
Int J Mol Sci. 2021 Jan 28;22(3):1308. doi: 10.3390/ijms22031308.
7
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.SARS-CoV-2 的 ORF6、ORF8 和核衣壳蛋白抑制 I 型干扰素信号通路。
Virus Res. 2020 Sep;286:198074. doi: 10.1016/j.virusres.2020.198074. Epub 2020 Jun 23.
8
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
9
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.SARS-CoV-2 通过干扰剪接、翻译和蛋白质运输来抑制宿主防御。
Cell. 2020 Nov 25;183(5):1325-1339.e21. doi: 10.1016/j.cell.2020.10.004. Epub 2020 Oct 8.
10
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.

引用本文的文献

1
Lower cancer incidence three years after COVID-19 infection in a large veteran population.在一大群退伍军人中,新冠病毒感染三年后癌症发病率降低。
PLoS One. 2025 Aug 25;20(8):e0318131. doi: 10.1371/journal.pone.0318131. eCollection 2025.
2
Post-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes.新冠后代谢后遗症:新发和加重型糖尿病的威胁日益增加。
Biomedicines. 2025 Jun 16;13(6):1482. doi: 10.3390/biomedicines13061482.
3
NSP6 regulates calcium overload-induced autophagic cell death and is regulated by KLHL22-mediated ubiquitination.

本文引用的文献

1
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.TNF-α 和 IFN-γ 的协同作用可引发 SARS-CoV-2 感染和细胞因子休克综合征中的炎症细胞死亡、组织损伤和死亡。
Cell. 2021 Jan 7;184(1):149-168.e17. doi: 10.1016/j.cell.2020.11.025. Epub 2020 Nov 19.
2
β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.β 冠状病毒利用溶酶体而不是生物合成分泌途径进行出芽。
Cell. 2020 Dec 10;183(6):1520-1535.e14. doi: 10.1016/j.cell.2020.10.039. Epub 2020 Oct 27.
3
Evasion of Type I Interferon by SARS-CoV-2.
NSP6调节钙超载诱导的自噬性细胞死亡,并受KLHL22介导的泛素化作用调控。
J Adv Res. 2025 Aug;74:303-318. doi: 10.1016/j.jare.2025.05.031. Epub 2025 May 13.
4
An isothermal calorimetry assay for determining steady state kinetic and Ensitrelvir inhibition parameters for SARS-CoV-2 3CL-protease.一种用于测定新型冠状病毒 3CL 蛋白酶稳态动力学和恩昔替尼抑制参数的等温滴定量热法检测。
Sci Rep. 2024 Dec 31;14(1):32175. doi: 10.1038/s41598-024-81990-y.
5
Rap1b: A cytoskeletal regulator Advantageous to viral infection.Rap1b:一种有利于病毒感染的细胞骨架调节因子
iScience. 2024 Sep 24;27(10):111023. doi: 10.1016/j.isci.2024.111023. eCollection 2024 Oct 18.
6
Characterization of the SARS-CoV-2 Genome 3'-Untranslated Region Interactions with Host MicroRNAs.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组3'非翻译区与宿主微小RNA的相互作用特征
ACS Omega. 2024 Aug 16;9(34):36148-36164. doi: 10.1021/acsomega.4c01050. eCollection 2024 Aug 27.
7
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.新冠疫情期间和之后对 SARS-CoV-2 发病机制的新认识。
Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.
8
Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶对 TRMT1 tRNA 修饰酶的蛋白水解切割和失活。
Elife. 2024 May 30;12:RP90316. doi: 10.7554/eLife.90316.
9
Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.尼曼-匹克C1样蛋白1(NPC1L1)与血管紧张素转换酶2(ACE2)受体的共表达协同增强严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的进入和融合。
Biomedicines. 2024 Apr 8;12(4):821. doi: 10.3390/biomedicines12040821.
10
COVID-19-Induced Diabetes Mellitus: Comprehensive Cellular and Molecular Mechanistic Insights.COVID-19 诱发的糖尿病:细胞与分子机制的全面见解
Pathophysiology. 2024 Apr 8;31(2):197-209. doi: 10.3390/pathophysiology31020016.
SARS-CoV-2 对 I 型干扰素的逃避。
Cell Rep. 2020 Oct 6;33(1):108234. doi: 10.1016/j.celrep.2020.108234. Epub 2020 Sep 19.
4
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.SARS-CoV-2 感染依赖于细胞表面的肝素硫酸和 ACE2。
Cell. 2020 Nov 12;183(4):1043-1057.e15. doi: 10.1016/j.cell.2020.09.033. Epub 2020 Sep 14.
5
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.
6
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19.靶向 SARS-CoV-2 生命周期各个阶段的药物:探索治疗 COVID-19 的有前途的药物。
Cell Signal. 2020 Oct;74:109721. doi: 10.1016/j.cellsig.2020.109721. Epub 2020 Jul 22.
7
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
8
Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.在 SARS-CoV-2 的早期进化过程中发现并鉴定了 ORF7b 和 ORF8 中 382 个核苷酸的缺失。
mBio. 2020 Jul 21;11(4):e01610-20. doi: 10.1128/mBio.01610-20.
9
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.严重 COVID-19 患者的 I 型干扰素活性和炎症反应受损。
Science. 2020 Aug 7;369(6504):718-724. doi: 10.1126/science.abc6027. Epub 2020 Jul 13.
10
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.新冠病毒感染的全球磷酸化组景观。
Cell. 2020 Aug 6;182(3):685-712.e19. doi: 10.1016/j.cell.2020.06.034. Epub 2020 Jun 28.